Report Company Directory
- Ohr Pharmaceutical, Inc. Announces Stockholder Approval of Merger Agreement with NeuBase Therapeutics, Inc. by GlobeNewsWire
- Ohr Pharmaceutical Urges Stockholders to Vote “FOR†Merger with NeuBase Therapeutics at Special Meeting on July 10, 2019 by GlobeNewsWire
- Ohr Pharmaceutical Reports Financial Results for the Fiscal Second Quarter of 2019 by GlobeNewsWire
- Ohr Pharmaceutical Regains Compliance with NASDAQ Listing Requirements by GlobeNewsWire
- Ohr Pharmaceutical Reports Financial Results for the Fiscal First Quarter of 2019 by GlobeNewsWire
- Ohr Pharmaceutical Announces Reverse Stock Split to be Effective February 4, 2019 by GlobeNewsWire
- Ohr Pharmaceutical, Inc. Announces Merger Agreement with NeuBase Therapeutics, Inc. by GlobeNewsWire
- Ohr Pharmaceutical Reports Fiscal Third Quarter 2018 Financial Results by GlobeNewsWire
- The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Ohr Pharmaceutical, Inc. Shareholders and a Lead Plaintiff Deadline of April 16, 2018 by BusinessWire
- OHRP EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Ohr Pharmaceutical, Inc. and a Lead Plaintiff Deadline of April 16, 2018 by BusinessWire